In its first foray into the capital markets in five years, NeuroSearch aims to raise DKK350 million (US$60.1 million) to DKK 400 million in a rights issue to support its planned acquisition of A. Carlsson Research AB in a combined cash and shares deal valued at up to SEK875 million (US$121.2 million). (BioWorld International)
In its first foray into the capital markets in five years, NeuroSearch aims to raise DKK350 million (US$60.1 million) to DKK 400 million in a rights issue to support its planned acquisition of A. Carlsson Research AB in a combined cash and shares deal valued at up to SEK875 million (US$121.2 million). (BioWorld International)
The Singapore-based company also banked $25 million, which represents the first closing of a $30 million venture capital round led by Aravis Venture Associates AG, of Zurich, Switzerland, and Bio*One Capital Pte. Ltd., of Singapore. (BioWorld International)
The Singapore-based company also banked $25 million, which represents the first closing of a $30 million venture capital round led by Aravis Venture Associates AG, of Zurich, Switzerland, and Bio*One Capital Pte. Ltd., of Singapore. (BioWorld International)
